Testing effectiveness (Phase 2)Study completedNCT01217060What this trial is testingTrimodality Management of T1b Esophageal CancersWho this might be right forEsophageal Cancer M.D. Anderson Cancer Center 4
Early research (Phase 1)Looking for participantsNCT04389632What this trial is testingSigvotatug Vedotin in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more Seagen, a wholly owned subsidiary of Pfizer 1,006
Early research (Phase 1)Study completedNCT04242199What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more Incyte Corporation 182
Not applicableUnknownNCT01240369What this trial is testingAssociation Between VEGF-C and miRNA and Clinical Non-small Cell Lung Cancer and Esophagus Squamous Cell CarcinomaWho this might be right forVEGFC Protein in SerumVEGFC Protein in Non Small Cell Lung CancerVEGFC Protein in ESCC+2 more China Medical University Hospital 250
Not applicableStudy completedNCT05526456What this trial is testingMapping of Lymph Node Metastasis and Survival For pN+ Superficial Esophageal Squamous Cell CarcinomaWho this might be right forNational Cancer Center/Cancer Hospital National Cancer Center, China 207
Large-scale testing (Phase 3)Study completedNCT00047112What this trial is testingSurgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal CancerWho this might be right forEsophageal Cancer Federation Francophone de Cancerologie Digestive 195
Early research (Phase 1)Study completedNCT04121286What this trial is testingJAB-3312 in Adult Patients With Advanced Solid Tumors in ChinaWho this might be right forNon-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more Allist Pharmaceuticals, Inc. 17
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)UnknownNCT05044728What this trial is testingExploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest.Who this might be right forNon-small Cell Lung CancerEsophageal Squamous Cell Carcinoma Sichuan Cancer Hospital and Research Institute 80
Testing effectiveness (Phase 2)Looking for participantsNCT05910827What this trial is testingStudy of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers, and HMBD-001 + Cetuximab in Advanced Squamous Cell CancersWho this might be right forAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Esophageal Squamous Cell Carcinoma+2 more Hummingbird Bioscience
Large-scale testing (Phase 3)UnknownNCT01745107What this trial is testingEfficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;Who this might be right forEsophageal NeoplasmEsophageal Cancer TNM Staging Primary Tumor (T) T2Esophageal Cancer TNM Staging Primary Tumor (T) T3+2 more Chinese Academy of Medical Sciences 240
Early research (Phase 1)Study completedNCT03708328What this trial is testingA Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid TumorsWho this might be right forSolid TumorsMetastatic MelanomaNon-small Cell Lung Cancer (NSCLC)+2 more Hoffmann-La Roche 134
Testing effectiveness (Phase 2)Looking for participantsNCT05281003What this trial is testingPembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)Who this might be right forEsophageal Squamous Cell Carcinoma Fudan University 128
Testing effectiveness (Phase 2)Looking for participantsNCT06663059What this trial is testingAdebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles StudyWho this might be right forEsophageal Cancer Tang-Du Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT06056336What this trial is testingPerioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell CarcinomaNeoadjuvant ChemoimmunotherapyAdjuvant Therapy Guo Xufeng 73
Not applicableStudy completedNCT02850991What this trial is testingDifferent Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal CarcinomaWho this might be right forEsophageal Cancer Peking University Cancer Hospital & Institute 167
Not applicableLooking for participantsNCT03734952What this trial is testingPostoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant ChemoradiotherapyWho this might be right forRadiation Oncology Fujian Medical University Union Hospital 537
Early research (Phase 1)Study completedNCT06549816What this trial is testingSGN-B6A in Chinese Participants With Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckEsophageal Squamous Cell Carcinoma+3 more Seagen, a wholly owned subsidiary of Pfizer 6
Testing effectiveness (Phase 2)Looking for participantsNCT06047379What this trial is testingSafety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisWho this might be right forDiffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more Neonc Technologies, Inc. 134
Testing effectiveness (Phase 2)UnknownNCT04506138What this trial is testingCamrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Zhejiang Cancer Hospital 46